TY  - JOUR
AU  - Feliu, Jaime
AU  - García-Carbonero, Rocio
AU  - Capdevila, Jaume
AU  - Guasch, Inmaculada
AU  - Alonso-Orduna, Vicente
AU  - Lopez, Carlos
AU  - Garcia-Alfonso, Pilar
AU  - Castanon, Carmen
AU  - Sevilla, Isabel
AU  - Cerezo, Laura
AU  - Conill, Carles
AU  - Quintana-Angel, Begona
AU  - Sanchez, Maria E
AU  - Ghanem, Ismael
AU  - Martin-Richard, Marta
AU  - Lopez-Gomez, Miriam
AU  - Leon, Ana
AU  - Caro, Monica
AU  - Fernandez, Teresa
AU  - Maurel, Joan
PY  - 2020
DO  - 10.1002/cam4.2722
SN  - 2045-7634
UR  - http://hdl.handle.net/20.500.12105/9294
AB  - AIM: VITAL, a phase II single-arm study, aimed to evaluate efficacy and safety of panitumumab addition to 5-fluorouracil (5-FU), mitomycin-C (MMC) and radiotherapy (RT) in patients with localized squamous cell carcinoma of the anal canal (SCCAC)....
LA  - eng
PB  - Cell Press
KW  - Chemotherapy
KW  - Radiotherapy
KW  - Rectal cancer
KW  - Target therapy
TI  - VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02)
TY  - journal article
ER  -